相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Placental transfer and pharmacokinetics of lopinavir and other protease inhibitors in combination with nevirapine at delivery
Andrea Gingelmaier et al.
AIDS (2006)
Increased expression of MDR1 mRNAs and P-glycoprotein in placentas from HIV-1 infected women
M. Camus et al.
PLACENTA (2006)
Maternal hepatotoxicity with nevirapine as part of combination antiretroviral therapy in pregnancy
F Lyons et al.
HIV MEDICINE (2006)
Nevirapine plasma exposure affects both durability of viral suppression and selection of Nevirapine primary resistance mutations in a clinical setting
DG de Requena et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A activity) during pregnancy
TS Tracy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Sex-based differences in saquinavir pharmacology and virologic response in AIDS Clinical Trials Group study 359
CV Fletcher et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Maternal toxicity with continuous nevirapine in pregnancy - Results from PACTG 1022
J Hitti et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2004)
Population pharmacokinetics of nevirapine in an unselected cohort of HIV-1-infected individuals
MMR de Maat et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Transplacental passage of protease inhibitors at delivery
C Marzolini et al.
AIDS (2002)
High exposure to nevirapine in plasma is associated with an improved virological response in HIV-1-infected individuals
AI Veldkamp et al.
AIDS (2001)
分享论文
